Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Diabetic Peripheral Neuropathic Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

July 15, 2020

Primary Completion Date

July 8, 2021

Study Completion Date

November 11, 2021

Conditions
Diabetic Peripheral Neuropathic Pain
Interventions
DRUG

LY3016859

Administered IV

DRUG

Placebo

Administered IV

Trial Locations (36)

16635

Altoona Center For Clinical Research, Duncansville

19610

Clinical Research Center of Reading,LLC, Wyomissing

27408

PharmQuest, Greensboro

29405

Coastal Carolina Research Center, North Charleston

32162

Synexus Clinical Research US, Inc - Orlando, The Villages

32806

Synexus - US, Orlando

33134

Clinical Research of South Florida, Coral Gables

33135

Suncoast Research Group, Miami

33180

VIN-Julie Schwartzbard, Aventura

33317

Martin E. Hale M.D., P.A., Plantation

33781

Synexus - US, Pinellas Park

34470

Renstar Medical Research, Ocala

35211

Simon Williamson Clinic, Birmingham

43213

Aventiv Research Inc, Columbus

44122

Rapid Medical Research, Cleveland

45236

Synexus - Cincinnati, Cincinnati

48706

Great Lakes Research Group, Inc., Bay City

60602

Synexus Clinical Research, Chicago

60611

Northwestern University, Chicago

63303

StudyMetrix Research, City of Saint Peters

66606

Cotton O'Neil Infusion Center, Topeka

68144

Synexus - US, Omaha

75234

Synexus - US, Dallas

78229

Synexus - US, San Antonio

84123

Synexus - US, Murray

85224

Synexus - US, Chandler

85306

Synexus Clinical Research - Glendale, Glendale

92103

Artemis Institute for Clinical Research, San Diego

92503

Artemis Institute for Clinical Research, Riverside

92614

Irvine Clinical Research Center, Irvine

98057

Rainier Clinical Research Center, Renton

02131

Boston Clinical Trials, Boston

01844

ActivMed Practices and Research, Methuen

02451

MedVadis Research Corporation, Waltham

98007-4209

Northwest Clinical Research Center, Bellevue

00909

Latin Clinical Trial Center, San Juan

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT04476108 - Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Diabetic Peripheral Neuropathic Pain | Biotech Hunter | Biotech Hunter